10 April 2020 | Views
Dr K Anand Kumar, Managing Director, Indian Immunologicals Limited talks about the company's plans on tackling the COVID-19 outbreak
"Indian Immunologicals Limited is going to commence research for developing a vaccine for COVID-19, by joining hands with Griffith University of Australia. IIL is committed to addressing critical public health needs by engaging in this research collaboration. The mission at IIL is to develop and supply vaccines that support the One Health initiative. IIL has taken up this initiative to develop a vaccine candidate for the pandemic. IIL’s leadership in producing safe and affordable human and veterinary vaccines will enable us to progress well in this endeavor."
- Dr K Anand Kumar, Managing Director, Indian Immunologicals Limited (IIL)